Average Co-Inventor Count = 2.35
ph-index = 69
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. University of California (21 from 15,294 patents)
2. Polares Medical Inc. (16 from 27 patents)
3. Atritech, Inc. (15 from 50 patents)
4. Atrionix, Inc. (14 from 23 patents)
5. Ev3 Sunnyvale, Inc. (8 from 10 patents)
6. Appriva Medical, Inc. (7 from 7 patents)
7. Other (5 from 831,952 patents)
8. Middle Peak Medical, Inc. (5 from 8 patents)
9. Evera Medical, Inc. (5 from 5 patents)
10. Ev3 Santa Rosa, Inc. (4 from 4 patents)
11. Edwards Lifesciences Ag (3 from 51 patents)
12. Edwards Lifesciences Corporation (1 from 1,599 patents)
13. Emory University (1 from 976 patents)
14. Ev3 Inc. (1 from 56 patents)
15. Ev3 Endovascular, Inc. (1 from 13 patents)
109 patents:
1. 12350153 - Systems and methods for transcatheter treatment of valve regurgitation
2. 12150856 - Device, system, and method for transcatheter treatment of valve regurgitation
3. 12109116 - Coaptation enhancement implant, system, and method
4. 11974921 - Mitral valve implants for the treatment of valvular regurgitation
5. 11678986 - Device, system, and method for transcatheter treatment of valve regurgitation
6. 11648119 - Coaptation enhancement implant, system, and method
7. 11648120 - Coaptation enhancement implant, system, and method
8. 11622759 - Systems and methods for anchoring an implant
9. 11497606 - Systems and methods for transcatheter treatment of valve regurgitation
10. 11426279 - Coaptation enhancement implant, system, and method
11. 11419722 - Device, system, and method for transcatheter treatment of valve regurgitation
12. 11413145 - Coaptation enhancement implant, system, and method
13. 11000372 - Systems and methods for transcatheter treatment of valve regurgitation
14. 10512542 - Device, system, and method for transcatheter treatment of valve regurgitation
15. 10500048 - Mitral valve implants for the treatment of valvular regurgitation